Riskpilot← Back to searchSign inGet full accessHgb Dermalife AB
ABActiveOrg 5569711632Blåhakegatan 4Medical specialists activities · NACE 8622Est. 20143 employees
Revenue 2024
SEK 9,7M
+118% vs 2023
EBITDA margin
74.7%
+197% vs 2023
Equity ratio
69.9%
Financial strength
Net profit 2024
SEK 5,5M
+184% vs 2023
| Revenue | SEK 9,7M | +118% |
| EBITDA | SEK 7,2M | +197% |
| Net profit | SEK 5,5M | +184% |
| Total assets | SEK 42,6M | +12% |
| Equity | SEK 29,8M | +20% |
| Employees | 3 | — |
Legal name
Hgb Dermalife AB
Org number
5569711632
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 maj 2014
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
SPECIALISTLÄKARE - HUDLÄKARE VERKSAMHET
Address
Blåhakegatan 4
Email
ndt@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 536 | 9 163 | 9 202 | 4 430 | 9 670 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 288 | 6 953 | 7 017 | 2 428 | 7 220 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 7 288 | 6 953 | 7 017 | 2 428 | 7 220 |
| Net financials | −15 | −17 | 31 | 508 | 575 |
| Profit before tax | 5 443 | 5 431 | 5 695 | 2 503 | 7 045 |
| Tax | −1 185 | −1 134 | −1 192 | −562 | −1 537 |
| Net profit | 4 258 | 4 297 | 4 503 | 1 941 | 5 508 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 938 | 30 824 | 36 134 | 38 102 | 42 621 |
| Equity | 15 677 | 19 474 | 23 427 | 24 818 | 29 777 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 236 | 2 820 | 2 824 | 2 967 | 1 778 |
| Total debt | 3 236 | 2 820 | 2 824 | 2 967 | 1 778 |
EBITDA margin
74.7%
This company
15.8%
Market median
+373% vs market
20202024
Equity ratio
69.9%
This company
38.2%
Market median
+83% vs market
20202024
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20202024
Net profit margin
57.0%
This company
8.1%
Market median
+604% vs market
20202024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hgb Dermalife AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Fredrik Andreas Johansson | Audit | 0 companies |
| Nadezda Tadic | Board of Directors | 0 companies |
| Dusko Tubin | Deputy Board Member | 0 companies |